Scripps Research Translational Institute, La Jolla, CA, USA.
Department of Molecular Medicine, Scripps Research, La Jolla, CA, USA.
Commun Biol. 2022 Oct 12;5(1):1084. doi: 10.1038/s42003-022-04056-7.
Atherogenesis involves an interplay of inflammation, tissue remodeling and cellular transdifferentiation (CTD), making it especially difficult to precisely delineate its pathophysiology. Here we use single-cell RNA sequencing and systems-biology approaches to analyze the transcriptional profiles of vascular smooth muscle cells (VSMCs) and endothelial cells (ECs) in calcified atherosclerotic core (AC) plaques and patient-matched proximal adjacent (PA) portions of carotid artery tissue from patients undergoing carotid endarterectomy. Our results reveal an anatomic distinction whereby PA cells express inflammatory mediators, while cells expressing matrix-secreting genes occupy a majority of the AC region. Systems biology analysis indicates that inflammation in PA ECs and VSMCs may be driven by TNFa signaling. Furthermore, we identify POSTN, SPP1 and IBSP in AC VSMCs, and ITLN1, SCX and S100A4 in AC ECs as possible candidate drivers of CTD in the atherosclerotic core. These results establish an anatomic framework for atherogenesis which forms the basis for exploration of a site-specific strategy for disruption of disease progression.
动脉粥样硬化的形成涉及炎症、组织重构和细胞转分化(CTD)的相互作用,因此很难精确描绘其病理生理学。在这里,我们使用单细胞 RNA 测序和系统生物学方法来分析接受颈动脉内膜切除术的患者颈动脉粥样硬化核心(AC)斑块和患者匹配的近侧相邻(PA)部位的血管平滑肌细胞(VSMCs)和内皮细胞(ECs)的转录谱。我们的结果揭示了一种解剖学差异,即 PA 细胞表达炎症介质,而表达基质分泌基因的细胞占据 AC 区域的大部分。系统生物学分析表明,PA ECs 和 VSMCs 中的炎症可能是由 TNFa 信号驱动的。此外,我们在 AC VSMCs 中鉴定出 POSTN、SPP1 和 IBSP,在 AC ECs 中鉴定出 ITLN1、SCX 和 S100A4 作为动脉粥样硬化核心中 CTD 的可能候选驱动因子。这些结果为动脉粥样硬化的形成建立了一个解剖学框架,为探索针对疾病进展的特定部位的策略奠定了基础。
Commun Biol. 2022-10-12
Atherosclerosis. 2011-10-25
Circ Res. 2014-12-18
Nat Commun. 2025-9-10
JACC Basic Transl Sci. 2025-7-16
Front Immunol. 2025-6-19
Nat Med. 2019-10-7
Arterioscler Thromb Vasc Biol. 2019-7-25
Nat Rev Cardiol. 2019-6-26
J Interferon Cytokine Res. 2019-6-13
Front Pharmacol. 2019-5-22